- Home
- CRDF vs USGO Comparison
CRDF vs USGO Comparison
Compare CRDF & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | USGO |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 134.7M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | CRDF | USGO |
|---|---|---|
| Price | $2.78 | $11.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $10.83 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 1.0M | 52.7K |
| Earning Date | 02-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $501,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.90 | $7.42 |
| 52 Week High | $4.99 | $14.93 |
Technical Indicators
Market Signals| Indicator | CRDF | USGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 66.49 |
| Support Level | $2.61 | $9.01 |
| Resistance Level | $3.31 | $9.66 |
| Average True Range (ATR) | 0.20 | 0.64 |
| MACD | -0.04 | 0.26 |
| Stochastic Oscillator | 27.03 | 76.95 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About USGO U.S. GoldMining Inc.
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.